At a glance
- Originator Eli Lilly and Company; GlaxoSmithKline; Merck KGaA
- Developer Eli Lilly and Company; Merck KGaA
- Class Cardiotonics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Heart failure